CH618431A5 - - Google Patents

Download PDF

Info

Publication number
CH618431A5
CH618431A5 CH1634376A CH1634376A CH618431A5 CH 618431 A5 CH618431 A5 CH 618431A5 CH 1634376 A CH1634376 A CH 1634376A CH 1634376 A CH1634376 A CH 1634376A CH 618431 A5 CH618431 A5 CH 618431A5
Authority
CH
Switzerland
Prior art keywords
group
compound
carbostyril
formula
hydroxy
Prior art date
Application number
CH1634376A
Other languages
English (en)
French (fr)
Inventor
Kazuyuki Nakagawa
Eiyu Yo
Shiro Yoshizaki
Shigeharu Tamada
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of CH618431A5 publication Critical patent/CH618431A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C07D215/32—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH1634376A 1976-10-08 1976-12-27 CH618431A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51121423A JPS609713B2 (ja) 1976-10-08 1976-10-08 カルボスチリル誘導体

Publications (1)

Publication Number Publication Date
CH618431A5 true CH618431A5 (de) 1980-07-31

Family

ID=14810767

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1634376A CH618431A5 (de) 1976-10-08 1976-12-27

Country Status (10)

Country Link
US (1) US4223137A (de)
JP (1) JPS609713B2 (de)
BE (1) BE849794A (de)
CA (1) CA1074801A (de)
CH (1) CH618431A5 (de)
DE (1) DE2658544C2 (de)
FR (1) FR2378521A1 (de)
GB (1) GB1540628A (de)
NL (1) NL174041C (de)
SE (1) SE434395B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
US4322425A (en) * 1980-03-14 1982-03-30 Otsuka Pharmaceutical Co., Ltd. Compositions for treating glaucoma
FI77852C (fi) * 1981-02-17 1989-05-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av nya, saosom hjaertmediciner anvaendbara substituerade amid- och (maettad heterocykel)karbonylkarbostyrilderivat.
US4456757A (en) * 1981-03-20 1984-06-26 Asahi Kasei Kogyo Kabushiki Kaisha Isoquinolinesulfonyl derivatives and process for the preparation thereof
ATE27451T1 (de) * 1981-03-24 1987-06-15 Ciba Geigy Ag Acyl-chinolinonderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische praeparate und ihre verwendung.
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
JPS60173736U (ja) * 1984-04-25 1985-11-18 株式会社昭和製作所 緩衝器用サブタンク
JPS61191767A (ja) * 1985-02-20 1986-08-26 辻本　夘太郎 植物張り家屋
JPS62113672A (ja) * 1985-11-12 1987-05-25 本田技研工業株式会社 リヤクツシヨン用リザ−ブタンク
JPS6348401U (de) * 1986-09-17 1988-04-01
JPS63106132A (ja) * 1986-10-24 1988-05-11 Mazda Motor Corp 車両のサスペンシヨン装置
US4687776A (en) * 1986-10-24 1987-08-18 Warner-Lambert Company Drug stabilization
JPS6374545U (de) * 1986-10-31 1988-05-18
JPS6417047U (de) * 1987-07-21 1989-01-27
US4894219A (en) * 1988-03-29 1990-01-16 University Of Florida Beta-agonist carbostyril derivatives, assay method and pharmacological composition
JPH026831U (de) * 1988-06-28 1990-01-17
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
US6653323B2 (en) 2001-11-13 2003-11-25 Theravance, Inc. Aryl aniline β2 adrenergic receptor agonists
US20030229058A1 (en) 2001-11-13 2003-12-11 Moran Edmund J. Aryl aniline beta2 adrenergic receptor agonists
EP1507754A1 (de) 2002-05-28 2005-02-23 Theravance, Inc. Alkoxy aryl beta-2 adrenergen rezeptoragonisten
AU2003297562A1 (en) * 2002-11-27 2004-06-23 Artesian Therapeutics, Inc. COMPOUNDS WITH MIXED PDE-INHIBITORY AND Beta-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE
TW200526547A (en) 2003-09-22 2005-08-16 Theravance Inc Amino-substituted ethylamino β2 adrenergic receptor agonists
TW200531692A (en) 2004-01-12 2005-10-01 Theravance Inc Aryl aniline derivatives as β2 adrenergic receptor agonists
FR2869893B1 (fr) * 2004-05-06 2006-07-28 Rhodia Chimie Sa Nouveaux granules de phosphates de calcium de type hydroxyapatite, leur procede de preparation et leurs applications
US7307076B2 (en) 2004-05-13 2007-12-11 Boehringer Ingelheim International Gmbh Beta agonists for the treatment of respiratory diseases
EP1789394A1 (de) * 2004-05-13 2007-05-30 Boehringer Ingelheim International Gmbh Hydroxy-substituierte benzkondensierte heterozyklen als betaagonisten zur behandlung von atemwegserkrankungen
US7402673B2 (en) 2004-06-03 2008-07-22 Theravance, Inc. Diamine β2 adrenergic receptor agonists
WO2006031556A2 (en) 2004-09-10 2006-03-23 Theravance. Inc. Amidine substituted aryl aniline compounds
GB0624757D0 (en) * 2006-12-12 2007-01-17 Sosei R & D Ltd Novel compounds
WO2014102594A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Substituted benzimidazole-type piperidine compounds and uses thereof
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201903832D0 (en) 2019-03-20 2019-05-01 Atrogi Ab New compounds and methods
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
EP4651867A1 (de) 2023-01-20 2025-11-26 Atrogi AB Beta 2-adrenergische rezeptoragonisten zur behandlung oder prävention von muskelschwund
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses
GB202403169D0 (en) 2024-03-05 2024-04-17 Atrogi Ab New medical uses
WO2025238248A1 (en) 2024-05-17 2025-11-20 Atrogi Ab USE OF β2-ADRENERGIC RECEPTOR AGONISTS IN TREATING MUSCLE WASTING

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975391A (en) * 1973-12-26 1976-08-17 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]ethyl-8-hydroxy-3,4-dihydrocarbostyril derivatives
JPS539227B2 (de) * 1973-12-26 1978-04-04
US4022776A (en) * 1974-01-31 1977-05-10 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]ethyl-8-hydroxycarbostyril derivatives
US4022784A (en) * 1974-01-31 1977-05-10 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-substituted-carbostyril and -3,4-dihydrocarbostyril derivatives
US3994901A (en) * 1974-06-13 1976-11-30 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxy-3,4-dihydrocarbostyril derivatives
FI58329C (fi) * 1974-11-08 1981-01-12 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av i 8-staellning substituerade 5-(3'-alkylamino-2'-hydroxi)propoxi-3,4-dihydrokarbostyrilderivat

Also Published As

Publication number Publication date
JPS5346983A (en) 1978-04-27
DE2658544C2 (de) 1985-10-03
SE7614539L (sv) 1978-04-09
JPS609713B2 (ja) 1985-03-12
SE434395B (sv) 1984-07-23
FR2378521B1 (de) 1979-06-29
BE849794A (fr) 1977-04-15
NL174041C (nl) 1984-04-16
CA1074801A (en) 1980-04-01
NL174041B (nl) 1983-11-16
AU2085576A (en) 1978-04-06
DE2658544A1 (de) 1978-04-13
GB1540628A (en) 1979-02-14
US4223137A (en) 1980-09-16
NL7614329A (nl) 1978-04-11
FR2378521A1 (fr) 1978-08-25

Similar Documents

Publication Publication Date Title
US4223137A (en) Carbostyril derivatives and process for preparing the same
CH653021A5 (fr) Derives piperidino, piperazino et homopiperazino, n-substitues par un groupe heterocyclique aromatique, leur procede de preparation et composition therapeutique les contenant.
EP0031753B1 (de) 2-(4-Piperidyl)-1-(4-chinolyl)-ethanon-Derivate, Zwischenprodukte und Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0346207B1 (de) 4-Amino-3-carboxynaphthyridin-Derivate, ihre Herstellung und pharmazeutische Zusammensetzungen
EP0053964B1 (de) 1(4-Chinolyl)äthanol- bzw. -propanolderivate, diese enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
EP0089894B1 (de) N-(2-(4-Hydroxy-3-methoxy-phenyl)-2-Hydroxy-Ethyl)3-Amino-1-(1-Benzimidazolyl)-Butan und Salze und Hydrate mit Beta-adrenergischer Aktivität, therapeutische Anwendungen und Verfahren zu deren Herstellung
EP0028959B1 (de) 5,8,13,13a -Tetrahydro-6H-dibenzo(a,g)chinolizin-Derivate, Verfahren zur Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
CH630629A5 (fr) Derives de la morphine, leur procede de preparation et leur application comme medicament.
MC1357A1 (fr) Derives de 2,3-indoledione
CH619453A5 (de)
EP0173585B1 (de) Arzneimittel auf Basis von Piperidinderivaten, Piperidinderivate und Verfahren zu ihrer Herstellung
JPH0578554B2 (de)
MC1186A1 (fr) Derives de quinazoline
US3091638A (en) N, n'-disubstituted hydrazine derivatives
WO2001044197A2 (fr) Derives de 2-phenyl-quinoleine et leur utilisation en tant qu'agent contractant des muscles lisses
BE852556A (fr) Derives de carbostyrile et leur procede de preparation
FR2522663A1 (fr) Nouveaux alcaloides ergopeptidiques, leur preparation et leur utilisation comme medicaments
FR3067711A1 (fr) Inhibiteurs de la catechol-o-methyl-transferase (comt)
CH616156A5 (de)
CA1217724A (fr) Compositions pharmaceutiques utiles comme antiarythmiques
EP0155888A1 (de) 1-(4-Quinolyl)-2-(4-piperidyl)-ethanamin und 1-(4-Quinolyl)-2-(4-piperidyl)-propanamin Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
CH638210A5 (fr) Ester derive de l'acide quinolopyranne-4-one-2-carboxylique, procede de sa preparation et utilisation de cet ester comme compose actif dans un medicament antiallergique pour le traitement de l'asthme.
KR850000031B1 (ko) 사이클로알카[4,5]피롤로[2,3-g]-이소퀴놀린의 제조방법
EP2938595B1 (de) Verfahren zur synthese eines hydrazin zur behandlung des papillomavirus
CA1116089A (fr) Compositions pharmaceutiques comprenant des medicaments a base de derives de la quinoleine

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased